Revision history of "GENERIC REVERSIBLE AND DIRECT COMPETITIVE THROMBIN INHIBITOR FOR THE TREATMENT OF THROMBOEMBOLIC EVENTS" (Q3175984)

11 October 2024

• curprev 09:4509:45, 11 October 2024‎ DG Regio talk contribs‎ 61,888 bytes −7‎ ‎Changed label, description and/or aliases in pt
• curprev 09:4509:45, 11 October 2024‎ DG Regio talk contribs‎ 61,895 bytes +20‎ ‎Set a claim value: summary (P836): Este projeto visa dar continuidade à política de desenvolvimento de especialidades farmacêuticas genéricas destinadas ao tratamento de patologias com elevado impacto socioeconómico, e propõe o desenvolvimento de um novo medicamento genérico de dabigatrano, cápsulas de 75 mg, 110 mg e 150 mg, para a prevenção e tratamento de eventos tromboembólicos em doentes adultos (tratamento de trombose venosa profunda e embolia pulmonar e embolia pulmonar, e pre...

23 March 2024

• curprev 11:2511:25, 23 March 2024‎ DG Regio talk contribs‎ 61,875 bytes +288‎ ‎Added qualifier: readability score (P590521): 0.3763844685799316

20 December 2023

• curprev 17:1617:16, 20 December 2023‎ DG Regio talk contribs‎ 61,587 bytes −113‎ ‎Changed an Item

12 June 2023

• curprev 14:3114:31, 12 June 2023‎ DG Regio talk contribs‎ 61,700 bytes +1,742‎ ‎Changed an Item

10 June 2023

• curprev 07:1707:17, 10 June 2023‎ Admin talk contribs‎ 59,958 bytes +437‎ BatchIngestion

18 August 2022

• curprev 04:0504:05, 18 August 2022‎ DG Regio talk contribs‎ 59,521 bytes +39,078‎ ‎Changed label, description and/or aliases in el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl, nl, fr, de, it, es, and other parts: Adding translations: el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl,

16 January 2022

• curprev 14:3114:31, 16 January 2022‎ DG Regio talk contribs‎ 20,443 bytes +1,979‎ ‎Changed label, description and/or aliases in it, and other parts: Adding Italian translations

17 December 2021

• curprev 15:4915:49, 17 December 2021‎ DG Regio talk contribs‎ 18,464 bytes +2,045‎ ‎Changed label, description and/or aliases in nl, and other parts: Adding Dutch translations

9 December 2021

• curprev 14:4414:44, 9 December 2021‎ DG Regio talk contribs‎ 16,419 bytes +2,049‎ ‎Changed label, description and/or aliases in de, and other parts: Adding German translations

4 December 2021

• curprev 13:3013:30, 4 December 2021‎ DG Regio talk contribs‎ 14,370 bytes +2,151‎ ‎Changed label, description and/or aliases in fr, and other parts: Adding French translations

12 October 2021

• curprev 18:3718:37, 12 October 2021‎ DG Regio talk contribs‎ 12,219 bytes +1,774‎ ‎Created claim: summary (P836): This project aims to give continuity to the policy of development of generic proprietary medicinal products intended for the treatment of pathologies with high socio-economic impact, and proposes the development of a new generic medicinal product of dabigatran, hard capsules of 75 mg, 110 mg and 150 mg, for the prevention and treatment of thromboembolic events in adult patients (treatment of deep venous thrombosis and pulmonary embolism and pulm...
• curprev 18:3718:37, 12 October 2021‎ DG Regio talk contribs‎ 10,445 bytes −1,774‎ ‎Removed claim: summary (P836): This project aims to give continuity to the policy of development of generic proprietary medicinal products intended for the treatment of pathologies with high socio-economic impact, and proposes the development of a new generic medicinal product of dabigatran, hard capsules of 75 mg, 110 mg and 150 mg, for the prevention and treatment of thromboembolic events in adult patients (treatment of deep venous thrombosis and pulmonary embolism and pu...
• curprev 18:3118:31, 12 October 2021‎ DG Regio talk contribs‎ 12,219 bytes +163‎ ‎Changed label, description and/or aliases in en: translated_label
• curprev 18:3118:31, 12 October 2021‎ DG Regio talk contribs‎ 12,056 bytes +1,774‎ ‎Created claim: summary (P836): This project aims to give continuity to the policy of development of generic proprietary medicinal products intended for the treatment of pathologies with high socio-economic impact, and proposes the development of a new generic medicinal product of dabigatran, hard capsules of 75 mg, 110 mg and 150 mg, for the prevention and treatment of thromboembolic events in adult patients (treatment of deep venous thrombosis and pulmonary embolism and pulm...

10 October 2021

• curprev 20:1220:12, 10 October 2021‎ DG Regio talk contribs‎ 10,282 bytes +427‎ ‎Changed an Item: Edited by the materialized bot - inferring region from the coordinates

9 October 2021

• curprev 15:0815:08, 9 October 2021‎ DG Regio talk contribs‎ 9,855 bytes +499‎ ‎Changed an Item: Edited by the infer coords bot - inferring coordinates from location

8 October 2021

• curprev 10:4510:45, 8 October 2021‎ DG Regio talk contribs‎ 9,356 bytes −10‎ ‎Changed label, description and/or aliases in en
• curprev 10:4510:45, 8 October 2021‎ DG Regio talk contribs‎ 9,366 bytes +9,366‎ ‎Created a new Item